Machine Learning–Based Survival Prediction Models for Progression-Free and Overall Survival in Advanced-Stage Hodgkin Lymphoma
Authors:
- Rasmus Rask Kragh JørgensenRJRasmus Rask Kragh Jørgensen
- Fanny BergströmFBFanny Bergström
- Sandra ElorantaSESandra Eloranta
- Knut Bjøro SmelandKSKnut Bjøro Smeland
- Alexander FossåAFAlexander Fosså
- Martin HutchingsMHMartin Hutchings
- Rasmus Bo Dahl-SørensenRDRasmus Bo Dahl-Sørensen
- Ingrid GlimeliusIGIngrid Glimelius
- Karin E SmedbyKSKarin E Smedby
Open Access
- 1 April 2024
- journal article
- research article
- Published by American Society of Clinical Oncology (ASCO) in JCO Clinical Cancer Informatics
- Vol. 8 (8) , e2300255
Abstract
PURPOSE: Patients diagnosed with advanced-stage Hodgkin lymphoma (aHL) have historically been risk-stratified using the International Prognostic Score (IPS). This study investigated if a machine learning (ML) approach could outperform existing models when it comes to predicting overall survival (OS) and progression-free survival (PFS). PATIENTS AND METHODS: This study used patient data from the Danish National Lymphoma Register for model development (development cohort). The ML model was developed using stacking, which combines several predictive survival models (Cox proportional hazard, flexible parametric model, IPS, principal component, penalized regression) into a single model, and was compared with two versions of IPS (IPS-3 and IPS-7) and the newly developed aHL international prognostic index (A-HIPI). Internal model validation was performed using nested cross-validation, and external validation was performed using patient data from the Swedish Lymphoma Register and Cancer Registry of Norway (validation cohort). RESULTS: In total, 707 and 760 patients with aHL were included in the development and validation cohorts, respectively. Examining model performance for OS in the development cohort, the concordance index (C-index) for the ML model, IPS-7, IPS-3, and A-HIPI was found to be 0.789, 0.608, 0.650, and 0.768, respectively. The corresponding estimates in the validation cohort were 0.749, 0.700, 0.663, and 0.741. For PFS, the ML model achieved the highest C-index in both cohorts (0.665 in the development cohort and 0.691 in the validation cohort). The time-varying AUCs for both the ML model and the A-HIPI were consistently higher in both cohorts compared with the IPS models within the first 5 years after diagnosis. CONCLUSION: The new prognostic model for aHL on the basis of ML techniques demonstrated a substantial improvement compared with the IPS models, but yielded a limited improvement in predictive performance compared with the A-HIPI.Keywords
This publication has 36 references indexed in Scilit:
- A novel machine learning model with Stacking Ensemble Learner for predicting emergency readmission of heart-disease patientsDecision Analytics Journal, 2023
- Radiation Therapy for Advanced-Stage Hodgkin LymphomaAdvances in Radiation Oncology, 2020
- Clinical Prediction Models2019
- Time-Dependent AUC with Right-Censored Data: A Survey2013
- Estimating and comparing time‐dependent areas under receiver operating characteristic curves for censored event times with competing risksStatistics in Medicine, 2013
- Reduced-intensity chemotherapy and PET-guided radiotherapy in patients with advanced stage Hodgkin's lymphoma (HD15 trial): a randomised, open-label, phase 3 non-inferiority trialThe Lancet, 2012
- On the C‐statistics for evaluating overall adequacy of risk prediction procedures with censored survival dataStatistics in Medicine, 2011
- Data quality at the Cancer Registry of Norway: An overview of comparability, completeness, validity and timelinessEuropean Journal of Cancer, 2009
- Assessment and comparison of prognostic classification schemes for survival dataStatistics in Medicine, 1999
- A note on quantifying follow-up in studies of failure timeControlled Clinical Trials, 1996